Tanshinone IIA inhibits neuronal ferroptosis and relieves cerebral ischemia‒reperfusion injury by regulating miR-449a/ACSL4
- PMID: 40542896
- DOI: 10.1007/s11011-025-01660-4
Tanshinone IIA inhibits neuronal ferroptosis and relieves cerebral ischemia‒reperfusion injury by regulating miR-449a/ACSL4
Abstract
Cerebral ischemia‒reperfusion injury (CI/RI) plays a significant role in the initiation of ischemic stroke. This study aimed to explore the influence of Tan (tanshinone) IIA in the treatment of neuronal ferroptosis induced by CI/RI, along with the associated molecular mechanisms. A CI/RI model was created by occluding the middle cerebral artery in rats (MCAO/R). A cellular CI/RI model was established with SH-SY5Y cells that were subjected to oxygen‒glucose deprivation followed by subsequent reperfusion (OGD/R). The optimal concentration for maintaining cell viability was evaluated through the CCK-8 assay. The expression levels of ferroptosis and oxidative stress-related genes in rat brain tissue and SH-SY5Y cells were determined, and the molecular mechanism by which Tan IIA regulates ferroptosis during CI/RI treatment was verified by bioinformatics analysis, RT‒qPCR, and dual-luciferase reporter assays. The results revealed that Tan IIA relieved CI/RI injury and inflammation by inhibiting ferroptosis in MCAO/R rat brain neurons. Our experimental results demonstrated that Tan IIA suppressed the progression of OGD/R and alleviated inflammation in SH-SY5Y cells. Ferroptosis affected the concentrations of Fe2+, ROS, and MDA in the CI/RI model while simultaneously increasing the expression of miR-449a. In terms of the molecular mechanism, Tan IIA inhibited OGD/R-induced neural ferroptosis, and this mechanism of action may involve Tan IIA promoting the downregulation of ACSL4 expression by targeting miR-449a within cells, thereby inhibiting ferroptosis in cells induced by OGD/R. Our research results indicate that Tan IIA relieved CI/RI injury and inflammation by alleviating neuronal ferroptosis, and this regulatory effect may be achieved through the miR-449a/ACSL4 molecular axis.
Keywords: Cerebral ischemia‒reperfusion injury; Ferroptosis; MiR-449a/ACSL4; Neuronal cells; Tan IIA.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. All animal experimental protocols were approved by the Animal Experiment Ethics Committee, and the animal procedures adhered to the ARRIVE guidelines 2.0. Competing interests: The authors declare no competing interests.
References
-
- Buckley P (1985) Amplification of oesophageal sounds. Anaesthesia 40:712. https://doi.org/10.1111/j.1365-2044.1985.tb10977.x - DOI
-
- Cai M, Guo Y, Wang S, Wei H, Sun S, Zhao G, Dong H (2017) Tanshinone IIA elicits neuroprotective effect through activating the nuclear factor erythroid 2-Related factor-dependent antioxidant response. Rejuven Res 20:286–297. https://doi.org/10.1089/rej.2016.1912 - DOI
-
- Chen W, Li X, Guo S, Song N, Wang J, Jia L, Zhu A (2019) Tanshinone IIA harmonizes the crosstalk of autophagy and polarization in macrophages via miR-375/KLF4 pathway to attenuate atherosclerosis. Int Immunopharmacol 70:486–497. https://doi.org/10.1016/j.intimp.2019.02.054 - DOI
-
- Chi M, Lin Z, Lee C, Huang C, Peng K, Lin C, Lee H, Fang M, Chiang Y (2023) Tanshinone IIA suppresses burning incense-induced oxidative stress and inflammatory pathways in astrocytes. Ecotoxicol Environ Saf. https://doi.org/10.1016/j.ecoenv.2023.114987 - DOI
-
- Cui Y, Zhang Y, Zhao X, Shao L, Liu G, Sun C, Xu R, Zhang Z (2021) ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation. Brain Behav Immun 93:312–321. https://doi.org/10.1016/j.bbi.2021.01.003 - DOI
MeSH terms
Substances
Grants and funding
- 202401AY070001-142/Joint Special-General program of Kunming Medical University
- 2023YJKTZ04/Hospital-level scientific research project of the First Hospital of Qujing in 2023
- Medical Development of Yunnan Health Office (2023) Number 10/Provincial key clinical specialty Construction Project of Yunnan Province during the 14th Five-Year Plan period
LinkOut - more resources
Full Text Sources
